Monte Rosa Therapeutics (NASDAQ:GLUE) Given New $10.00 Price Target at Wells Fargo & Company
Monte Rosa Therapeutics (NASDAQ:GLUE – Free Report) had its target price trimmed by Wells Fargo & Company from $11.00 to $10.00 in a research note released on Friday morning,Benzinga reports. The firm currently has an equal weight rating on the stock. Other research analysts have also recently issued reports about the stock. Wedbush restated an […]
Monte Rosa Therapeutics (NASDAQ:GLUE – Free Report) had its target price trimmed by Wells Fargo & Company from $11.00 to $10.00 in a research note released on Friday morning,Benzinga reports. The firm currently has an equal weight rating on the stock. Other research analysts have also recently issued reports about the stock. Wedbush restated an […]
